Literature DB >> 21901275

Allelic loss of 10q23.3, the PTEN gene locus in cervical carcinoma from Northern Indian population.

M Moshahid Alam Rizvi1, M Shabbir Alam, Syed Jafar Mehdi, Asgar Ali, Swaraj Batra.   

Abstract

Cervical cancer is one of the most common malignant diseases affecting women worldwide. Studies on loss of heterozygosity have been made for PTEN gene specific microsatellite markers in malignancies like breast, ovary and lungs and the results have shown a significant association. However the role of this gene is not clearly understood in cervical cancer from Indian population. A total of 135 cervical carcinoma tissues samples were analyzed for loss of heterozygosity. DNA was isolated from the samples and their matched control specimens. Polymerase chain reaction was performed using primer specific for two intragenic markers (D10S198 & D10S192) and one marker (D10S541) in flanking region and further electrophoresed on 8% denaturing polyacrylamide gel. Overall, 31 out of 133(23%) informative cases showed loss of heterozygosity in at least one locus in the region examined. The percentage of loss of heterozygosity for these markers ranged from 8% (D10S192) to 13% (D10S198). Loss of heterozygosity was more frequently detected in intragenic region (D10S198 & D10S192) than in flanking region, D10S541 (21% versus 9%). These data argue that PTEN is a tumor suppressor gene whose inactivation may play an important role in the carcinoma of uterine cervix.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21901275     DOI: 10.1007/s12253-011-9446-z

Source DB:  PubMed          Journal:  Pathol Oncol Res        ISSN: 1219-4956            Impact factor:   3.201


  32 in total

Review 1.  The hallmarks of cancer.

Authors:  D Hanahan; R A Weinberg
Journal:  Cell       Date:  2000-01-07       Impact factor: 41.582

2.  FcgammaRIIb-mediated negative regulation of BCR signalling is associated with the recruitment of the MAPkinase-phosphatase, Pac-1, and the 3'-inositol phosphatase, PTEN.

Authors:  Kirsty S Brown; Derek Blair; Steven D Reid; Emma K Nicholson; Margaret M Harnett
Journal:  Cell Signal       Date:  2004-01       Impact factor: 4.315

3.  MSI/LOH and extron expression of the FHIT gene in gastric carcinoma.

Authors:  Yuping Xiao; Lili Mao; Chengbo Han; Jinyi Li; Lei Xu; Yan Xin
Journal:  Front Med China       Date:  2007-02

Review 4.  Effective screening programmes for cervical cancer in low- and middle-income developing countries.

Authors:  R Sankaranarayanan; A M Budukh; R Rajkumar
Journal:  Bull World Health Organ       Date:  2001-11-01       Impact factor: 9.408

5.  PTEN M-CBR3, a versatile and selective regulator of inositol 1,3,4,5,6-pentakisphosphate (Ins(1,3,4,5,6)P5). Evidence for Ins(1,3,4,5,6)P5 as a proliferative signal.

Authors:  Elaine A Orchiston; Deborah Bennett; Nick R Leslie; Rosemary G Clarke; Lucinda Winward; C Peter Downes; Stephen T Safrany
Journal:  J Biol Chem       Date:  2003-10-15       Impact factor: 5.157

6.  Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN.

Authors:  V Stambolic; A Suzuki; J L de la Pompa; G M Brothers; C Mirtsos; T Sasaki; J Ruland; J M Penninger; D P Siderovski; T W Mak
Journal:  Cell       Date:  1998-10-02       Impact factor: 41.582

7.  Pten is essential for embryonic development and tumour suppression.

Authors:  A Di Cristofano; B Pesce; C Cordon-Cardo; P P Pandolfi
Journal:  Nat Genet       Date:  1998-08       Impact factor: 38.330

8.  PTEN and TNF-alpha regulation of the intestinal-specific Cdx-2 homeobox gene through a PI3K, PKB/Akt, and NF-kappaB-dependent pathway.

Authors:  Sunghoon Kim; Claire Domon-Dell; Qingding Wang; Dai H Chung; Antonio Di Cristofano; Pier Paolo Pandolfi; Jean-Noel Freund; B Mark Evers
Journal:  Gastroenterology       Date:  2002-10       Impact factor: 22.682

Review 9.  Linking molecular diagnostics to molecular therapeutics: targeting the PI3K pathway in breast cancer.

Authors:  Gordon B Mills; Elise Kohn; Yiling Lu; Astrid Eder; Xianjun Fang; Hongwei Wang; Robert C Bast; Joe Gray; Robert Jaffe; Gabriel Hortobagyi
Journal:  Semin Oncol       Date:  2003-10       Impact factor: 4.929

10.  Molecular characterisation of ERG, ETV1 and PTEN gene loci identifies patients at low and high risk of death from prostate cancer.

Authors:  A H M Reid; G Attard; L Ambroisine; G Fisher; G Kovacs; D Brewer; J Clark; P Flohr; S Edwards; D M Berney; C S Foster; A Fletcher; W L Gerald; H Møller; V E Reuter; P T Scardino; J Cuzick; J S de Bono; C S Cooper
Journal:  Br J Cancer       Date:  2010-01-26       Impact factor: 7.640

View more
  10 in total

Review 1.  Therapeutic effects of date fruits (Phoenix dactylifera) in the prevention of diseases via modulation of anti-inflammatory, anti-oxidant and anti-tumour activity.

Authors:  Arshad H Rahmani; Salah M Aly; Habeeb Ali; Ali Y Babiker; Sauda Srikar; Amjad A Khan
Journal:  Int J Clin Exp Med       Date:  2014-03-15

2.  Inhibition of miRNA-21 attenuates the proliferation and metastasis of human osteosarcoma by upregulating PTEN.

Authors:  Chen Li; Binwu Xu; Xinxin Miu; Zhongbo Deng; Hang Liao; Liang Hao
Journal:  Exp Ther Med       Date:  2017-11-10       Impact factor: 2.447

3.  Expressional evaluation of vascular endothelial growth factor (VEGF) protein in urinary bladder carcinoma patients exposed to cigarette smoke.

Authors:  Arshad Rahmani; Mohammad Alzohairy; Habeeb Khadri; Ashish K Mandal; Moshahid A Rizvi
Journal:  Int J Clin Exp Pathol       Date:  2012-03-25

4.  Epidermal growth factor receptor pathway mutation and expression profiles in cervical squamous cell carcinoma: therapeutic implications.

Authors:  Sureewan Bumrungthai; Kavita Munjal; Shirish Nandekar; Kumarasen Cooper; Tipaya Ekalaksananan; Chamsai Pientong; Mark Francis Evans
Journal:  J Transl Med       Date:  2015-07-25       Impact factor: 5.531

Review 5.  Therapeutic Implications of Black Seed and Its Constituent Thymoquinone in the Prevention of Cancer through Inactivation and Activation of Molecular Pathways.

Authors:  Arshad H Rahmani; Mohammad A Alzohairy; Masood A Khan; Salah M Aly
Journal:  Evid Based Complement Alternat Med       Date:  2014-05-18       Impact factor: 2.629

Review 6.  The precision prevention and therapy of HPV-related cervical cancer: new concepts and clinical implications.

Authors:  Zheng Hu; Ding Ma
Journal:  Cancer Med       Date:  2018-09-14       Impact factor: 4.452

Review 7.  PTEN and Gynecological Cancers.

Authors:  Camilla Nero; Francesca Ciccarone; Antonella Pietragalla; Giovanni Scambia
Journal:  Cancers (Basel)       Date:  2019-09-28       Impact factor: 6.639

8.  Downregulation of MicroRNA-147 Inhibits Cell Proliferation and Increases the Chemosensitivity of Gastric Cancer Cells to 5-Fluorouracil by Directly Targeting PTEN.

Authors:  Jianjun Shen; Weina Niu; Hongbo Zhang; Ma Jun; Hongyan Zhang
Journal:  Oncol Res       Date:  2017-09-26       Impact factor: 5.574

9.  An Optimization-Driven Analysis Pipeline to Uncover Biomarkers and Signaling Paths: Cervix Cancer.

Authors:  Enery Lorenzo; Katia Camacho-Caceres; Alexander J Ropelewski; Juan Rosas; Michael Ortiz-Mojer; Lynn Perez-Marty; Juan Irizarry; Valerie Gonzalez; Jesús A Rodríguez; Mauricio Cabrera-Rios; Clara Isaza
Journal:  Microarrays (Basel)       Date:  2015-06

10.  Distribution of HPV Genotypes and Involvement of Risk Factors in Cervical Lesions and Invasive Cervical Cancer: A Study in an Indian Population.

Authors:  Shikha Srivastava; U P Shahi; Arti Dibya; Sadhana Gupta; Jagat K Roy
Journal:  Int J Mol Cell Med       Date:  2014
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.